RheumaKit-Tx: Treatment response prediction

The RheumaKit team is also currently developing tools for explicit treatment response prediction in the field of Rheumatoid Arthritis. At the same time, the tool can also be included in pharmaceutical or biotech companies clinical trials regarding biological DMARDs validation, nicely combined to the data mining expertise of DNAlytics, the developer of RheumaKit.

Congrats to @hadleywickham for receiving the COPSS award, 'Nobel prize of stats'! With the @rstudio team, they muta… https://t.co/3afGYDvDkH, Nov 20
Time2Work is the focus of the campaign "Don't Delay, Connect Today" from EULAR. It emphasizes the importance of ear… https://t.co/TA4TDHIhAZ, Oct 12
Tine Kold Olensen, Global Program Director @ferring, gave a talk on Nocturia modeling. This work has been performed… https://t.co/mXbahzUYOm, Oct 3
Participate to the 2nd course on synovial biopsies, this accessible noninvasive technology more and more used by rh… https://t.co/CrkTRxq4ir, Jul 9
Busy week for DNAlytics @eular Rheumatology Congress! One poster on Rheumatoid Arthritis patients stratification, s… https://t.co/KP3qRKpEv0, Jun 14